Introduction: With advances in clinical oncology, the burden of morbidity and mortality for
cancer survivors due to the cardiac side effects of the chemotherapy is steadily increasing …

Background Left ventricular dysfunction and cardiomyopathy are well documented adverse
effects associated with chemotherapy agents. Limited information exists regarding the …

Objectives The purpose of this study was to assess the associations between 3-dimensional
echocardiography (3DE)-derived changes in right ventricular (RV) volumes and strains with …

Cardiovascular disease is a leading cause of death in cancer survivors. It is critical to apply
new predictive and early diagnostic methods in this population, as this can potentially inform …

The involvement of the right ventricle (RV) in various cardiovascular pathologies is usually
explored and demonstrated after thorough research of the left ventricle (LV). This is also true …

Background A large number of chemotherapy‐induced cardiovascular complications were
discovered in studies over the last several decades. The focus of the majority of these …

Cardio-oncology guidelines, position statements and clinical trials have focused on the
cardiotoxic effects of cancer therapies upon the left ventricle (LV)(1, 2). However, cancer …

There are limited data on the effects of anthracyclines on right ventricular (RV) structure,
function, and tissue characteristics. The goal of this study was to investigate the effects of …

Background Chemotherapy-induced cardiotoxicity has become a prevalent complication.
Regular monitoring of patients who received chemotherapy using 3D strain parameters may …

Every year, more than a million people in the United States undergo chemotherapy or
radiation therapy for cancer, as estimated by the CDC. While chemotherapy has been an …